Early results with partial left ventriculectomy

Dilated cardiomyopathy remains a leading cause of heart failure with limited treatment options beyond transplantation. Prior research has shown that medical management often fails to improve cardiac function in advanced cases. No prior work had resolved whether surgical interventions could serve as alternatives to transplantation. Established knowledge includes the risks of long-term mechanical support devices and the scarcity of donor hearts. This paper's contribution focuses on a novel surgical approach—partial left ventriculectomy. The procedure's potential to reduce ventricular size and improve ejection fraction is a new area of investigation. This gap motivated a closer look at surgical outcomes in transplant candidates. The need for alternatives to transplantation remains unmet in clinical practice.

The study aimed to assess the role of partial left ventriculectomy in patients with dilated cardiomyopathy. Specifically, the researchers focused on heart transplant candidates, a population with limited treatment options. The motivation arose from the need to explore surgical alternatives to transplantation. The procedure involves resecting part of the left ventricle to reduce its size. Researchers also examined the impact of complex mitral valve repairs on outcomes. The goal was to determine if this surgery could serve as a bridge to transplantation. The study sought to evaluate early survival and functional improvements. The authors emphasized the need for improved selection criteria to avoid early failures.

The study included 53 patients with dilated cardiomyopathy who underwent partial left ventriculectomy. The majority (94%) were heart transplant candidates, with a mean age of 53 years. The surgical approach involved resecting the left ventricle and repairing the mitral valve. In some cases, mitral valve replacement was performed instead of repair. The Alfieri repair was used in 51 patients to approximate mitral valve leaflets. Posterior annuloplasty was added in 47 patients to stabilize the valve. In 27 patients, papillary muscles were divided and reimplanted. Echocardiography was used to assess changes in ventricular dimensions and function.

Echocardiography showed a significant decrease in left ventricular dimensions from 8.3 cm to 5.8 cm. Mitral regurgitation was reduced from 2.8+ to 0 in all patients. Forward ejection fraction improved from 15.7% to 32.7%. Cardiac index remained unchanged at 2.2 to 2.4 L/min per square meter. Eight patients (15%) required a left ventricular assist device perioperatively. One patient died, resulting in a 1.9% perioperative mortality rate. At 11 months, actuarial survival was 87%, and freedom from relisting for transplantation was 72%. These results suggest the surgery may serve as a bridge to transplantation.

The authors suggest that partial left ventriculectomy may serve as a biologic bridge to heart transplantation. The procedure showed improvements in ventricular size and ejection fraction. However, the authors caution that improved selection criteria are necessary to avoid early failures. The study's findings are limited by the need for longer follow-up and further data analysis. The authors propose that the operation could become an alternative to transplantation in some cases. The perioperative mortality rate was low at 1.9%, but this remains a concern. The authors emphasize the importance of careful patient selection. The results suggest the procedure may be beneficial for select patients.